Skip to main content

Advertisement

SpringerLink
Log in

Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation

  • ORIGINAL PAPER
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Background

Working memory as a part of higher-order executive functions is defined by the parallel storage and processing of information. Recent functional fMRI studies have revealed a functional, interregional disintegration of a neuronal network connecting cortical, subcortical and cerebellar regions in schizophrenic patients (SZ). Cognitive impairment in working memory is a core psychopathological correlate of schizophrenic symptoms. Atypical neuroleptics such as quetiapine have shown good efficacy in treating positive and negative symptoms. The presented study evaluated the impact of a neuroleptic steady state treatment with quetiapine on the altered working memory activation patterns in schizophrenia.

Methods

Patients were examined by fMRI at baseline and after 12 weeks of steady state treatment with quetiapine. Matched healthy controls (HC) underwent baseline examination. In the scanner, stimuli were presented in a 2-back and 0-back condition of a working memory (wm) paradigm, whereby a degraded and a non-degraded version were used each time. Additionally, behavioural responses (reaction time to target stimuli and error ratio) were measured.

Results

At baseline, healthy controls revealed increased activity in the frontal lobe, especially in regions of the prefrontal cortex. Compared to HC, SZ showed hypoactivation in the right dorsolateral prefrontal cortex (DLPFC) and the ventrolateral prefrontal cortex (VLPFC) bilaterally for the 2-back condition. In the 2-back degraded condition there was a hypoactivation in both, the right DLPFC and the VLPFC. Additionally, patients showed bilaterally decreased activation in the basalganglia in the 2-back and in the right caudatus in the 2-back degraded condition compared to healthy controls. After treatment with quetiapine, patients activations patterns were increased. The pre–post comparison of the 2-back condition revealed a significant increase of activation in the left VLPFC at a significance level of 0.001 (uncorrected). The 2-back degraded condition led to a significant activation pattern in the lingual gyrus and the right precuneus. In both wm conditions, at baseline there were no differences in reaction time but only a worse performance in SZ. After treatment, behavioural measurement of responses, including reaction time and performance, showed slight improvements in SZ, although these did not reach statistical significance.

Conclusions

The neuronal networks underlying working memory are clearly altered in schizophrenia. After 12 weeks of treatment with quetiapine monotherapy, patients showed significant clinical improvement and revealed increased BOLD activity in the VLPFC during a working memory task, although there was no improvement of cognitive performance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Andreasen NC (1989) The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry 162(7):49–58

    Google Scholar 

  2. Arvanitis LA, Miller BG (1997) Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel trial 13 study group. Biol Psychiatry 42(4):233–246

    Article  PubMed  CAS  Google Scholar 

  3. Barch DM, Braver TS, Nystrom LE, Forman SD, Noll DC, Cohen JD (1997) Dissociating working memory from task difficulty in human prefrontal cortex. Neuropsychologia 35(10):1373–1380

    Article  PubMed  CAS  Google Scholar 

  4. Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A 3rd, Noll DC, Cohen JD (2001) Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry 58(3):280–288

    Article  PubMed  CAS  Google Scholar 

  5. Bertolino A, Blasi G, Caforio G, Latorre V, De Candia M, Rubino V, Callicott JH, Mattay VS, Bellomo A, Scarabino T, Weinberger DR, Nardini M (2004) Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine. Biol Psychiatry 56(3):190–197

    Article  PubMed  CAS  Google Scholar 

  6. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, Trenary M, Tafalla R, Reynolds C, Bunney WE Jr (1992) Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 49:935–942

    PubMed  CAS  Google Scholar 

  7. Brett M, Penny WD, Kiebel SJ (2003) Introduction to random field theory. In: Frackowiak RSJ, Friston KJ, Frith C, Dolan R, Friston KJ, Price CJ, Zeki S, Ashburner J, Penny WD (eds) Human brain function, 2nd edn. Academic Press

  8. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Goldberg TE, Weinberger DR (1999) Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 9(1):20–26

    Article  PubMed  CAS  Google Scholar 

  9. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, Goldberg TE, Weinberger DR (2000) Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia. Cereb Cortex 10(11):1078–1092

    Article  PubMed  CAS  Google Scholar 

  10. Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR (2003) Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry 160(12):2209–2215

    Article  PubMed  Google Scholar 

  11. Chaudhury IB, Soni SD, Hellewell JSE, Deakin JWF (1997) Antisaccade, clinical and motor executive function in schizophrenia: effects of 5HT2 antagonist, cyproheptadine. Schizophre Res 112(24):212

    Google Scholar 

  12. Cuesta MJ, Peralta V, Zarzuela A (2001) Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 48(1):17–28

    Article  PubMed  CAS  Google Scholar 

  13. D’Esposito M, Postle BR, Rypma B (2000) Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies. Exp Brain Res 133(1):3–11

    Article  PubMed  CAS  Google Scholar 

  14. Erkwoh R, Sabri O, Schreckenberger M, Setani K, Aßfalg S, Sturz L, Fehler S, Pleßmann S (2002) Cerebral correlates of selective attention in schizophrenic patients with formal thought disorder: a controlled H215O-PET study. Psychiatry Res Neuroimaging 15(115):137–153

    Article  Google Scholar 

  15. Fahim C, Stip E, Mancini-Marie A, Gendron A, Mensour B, Beauregard M (2005) Differential hemodynamic brain activity in schizophrenia patients with blunted affect during quetiapine treatment. J Clin Psychopharmacol 25(4):367–371

    Article  PubMed  CAS  Google Scholar 

  16. Good MF, Kiss I, Buiteman C, Woodley H, Ruui Q, Whitehorn D, Kopala L (2002) Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysis. Br J Psychiatry 43:45–49

    Article  Google Scholar 

  17. Goldman-Rakic PS (1994) Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 6(4):348–357

    PubMed  CAS  Google Scholar 

  18. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T (1999) Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci 96(23):13432–13437

    Article  PubMed  CAS  Google Scholar 

  19. Jones HM, Brammer MJ, O’Toole M, Taylor T, Ohlsen RI, Brown RG, Purvis R, Williams S, Pilowsky LS (2004) Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging study. Biol Psychiatry 56:938–942

    Article  PubMed  CAS  Google Scholar 

  20. Kindermann SS, Brown GG, Zorrilla LE, Olsen RK, Jeste DV (2004) Spatial working memory among middle-aged and older patients with schizophrenia and volunteers using fMRI. Schizophr Res 68(2–3):203–216

    Article  PubMed  Google Scholar 

  21. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Saper CB, Warach S (1999) Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 45(9): 1128–1137

    Article  PubMed  CAS  Google Scholar 

  22. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL (2000) Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry. 15, 48(2):99–109

    Google Scholar 

  23. Menon RS (2001) Imaging function in the working brain with fMRI. Curr Opin Neurobiol 11(5):630–636

    Article  PubMed  CAS  Google Scholar 

  24. Möller HJ (1999a) Atypical neuroleptics: a new approach in the treatment of negative symptoms. Eur Arch Psychiatry Clin Neurosci 249(4):99–107

    Article  Google Scholar 

  25. Möller HJ (1999b) Can negative symptoms of schizophrenia be partially or totally controlled by antipsychotics? Eur Neuropsychopharmacol 9(5):135–136

    Article  Google Scholar 

  26. Möller HJ (2000) Results and methodological problems in the evaluation of newer atypical neuroleptics in the treatment of schizophrenic negative symptoms. Nervenarzt (71):345–353

  27. Mortimer AM, Dye S (1997) Remediation of neuropsychological impairments with clozapine. Schizophr Res 24:187

    Article  Google Scholar 

  28. Perlstein WM, Dixit NK, Carter CS, Noll DC, Cohen JD (2003) Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biol Psychiatry 53(1):25–38

    Article  PubMed  Google Scholar 

  29. Petrides M (2000) Dissociable roles of mid-dorsolateral prefrontal and anterior inferotemporal cortex in visual working memory. J Neurosci 20(19):7496–7503

    PubMed  CAS  Google Scholar 

  30. Purdon SE (2000) Measuring neuropsychological change in schizophrenia with novel antipsychotic medications. J Psychiatry Neurosci 25(2):108–116

    PubMed  CAS  Google Scholar 

  31. Purdon SE, Malla A, Labelle A, Lit W (2001) Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 26(2): 137–149

    PubMed  CAS  Google Scholar 

  32. Riedel M, Müller N, Strassnig M, Spellmann I, Engel RR, Musil R, Dehning S, Douhet A, Schwarz MJ, Möller HJ (2005) Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci 255:432–437

    Article  PubMed  Google Scholar 

  33. Robbins TW (1990) The case for frontostriatal dysfunction in schizophrenia. Schizophr Bull 16(3):391–402

    PubMed  CAS  Google Scholar 

  34. Scheuerecker J, Ufer S, Frodl T, Koutsouleris N, Zipse M, Zetzsche T, Wiesmann M, Albrecht J, Schmitt G, Möller HJ, Meisenzahl EM (2006) Cerebral changes and cognitive dysfunctions in medication-free schizophrenia-an fMRI study. J Psychiatr Res (1st revision)

  35. Schlosser R, Gesierich T, Kaufmann B, Vucurevic G, Hunsche S, Gawehn J, Stoeter P (2003) Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling. Neuroimage 19(3):751–763

    Article  PubMed  Google Scholar 

  36. Schmahmann JD, Sherman JC (1997) Cerebellar cognitive affective syndrome. Int rev Neurbiol 41:433–440

    Article  CAS  Google Scholar 

  37. Sharma T (2001) Quetiapine–efficacy in different domains. Eur Neuropsychopharmacol 11(4):385–390

    Article  Google Scholar 

  38. Stern CE, Owen AM, Tracey I, Look RB, Rosen BR, Petrides M (2000) Activity in ventrolateral and mid-dorsolateral prefrontal cortex during nonspatial visual working memory processing: evidence from functional magnetic resonance imaging. Neuroimage 11(5):392–399

    Article  PubMed  CAS  Google Scholar 

  39. Stip E, Fahim C, Mancini-Marie A, Bentaleb LA, Mensour B, Mendrek A, Beauregard M (2005) Restoration of frontal activation during a treatment with quetiapine: a fMRI study of blunted affect in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29(1):21–26

    Article  PubMed  CAS  Google Scholar 

  40. Velligan DJ, Newcomer J, Pultz J, Csernansky J, Hoff AL, Mahurin R, Miller AL (2002) Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res (53):239–248

    Article  Google Scholar 

  41. Weickert TW, Goldberg TE, Marenco S, Bigelow LB, Egan MF, Weinberger DR (2003) Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds. Neuropsychopharmacology 28(8):1491–1500

    Article  PubMed  CAS  Google Scholar 

  42. Weinberger DR, Berman KF (1996) Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci 351(1346):1495–503

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

The study was supported by AstraZeneca Pharmaceuticals, Wilmington, Delaware, USA.

Author information

Authors and Affiliations

  1. Dept. of Psychiatry, Ludwig-Maximilians-University of Munich, Nussbaumstrasse 7, 80336, Munich, Germany

    E.M. Meisenzahl, J. Scheuerecker, M. Zipse, S. Ufer, T. Frodl, N. Koutsouleris, T. Zetzsche, G. Schmitt, M. Riedel, I. Spellmann, S. Dehning & H.J. Möller

  2. Dept. of Neuroradiology, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany

    M. Wiesmann, J. Linn & H. Brückmann

Authors
  1. E.M. Meisenzahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Scheuerecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Zipse
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Ufer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Wiesmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. Frodl
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N. Koutsouleris
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T. Zetzsche
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Schmitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Riedel
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. I. Spellmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. S. Dehning
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. J. Linn
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. H. Brückmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. H.J. Möller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E.M. Meisenzahl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meisenzahl, E., Scheuerecker, J., Zipse, M. et al. Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation. Eur Arch Psychiatry Clin Neurosci 256, 522–531 (2006). https://doi.org/10.1007/s00406-006-0687-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-006-0687-x

Keywords

Search

Navigation